30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Swirsky Douglas J

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -16% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Swirsky Douglas J's trades of MaxCyte Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-19 2026-03-17
US MaxCyte Inc (MXCT)
S Sale
88,498 -4.8%
219.79
US$2,456,410 		88,498 -4.8% 219.79 US$2,456,410
2025-08-13 2025-08-13
US MaxCyte Inc (MXCT)
B Purchase
24,820 -42.6%
49.10
US$2,424,013 		24,820 -42.6% 49.10 US$2,424,013
2025-03-20 2025-03-18
US MaxCyte Inc (MXCT)
S Sale
40,915 -23.2%
176.72
US$2,240,897 		40,915 -23.2% 176.72 US$2,240,897
2021-09-14 2021-09-14
B Purchase
25,000 +inf%
1.04
US$26,000 		25,000 +inf% 1.04 US$26,000
2019-01-30 2019-01-29
B Purchase
50,000 +inf%
0.63
US$31,720 		50,000 +inf% 0.63 US$31,720